What is Alphaform AG?
Alphaform AG, together with its subsidiaries, engages in the provision of generative 3D layering technologies, and manufacture of medical products in Germany, rest of Europe, Turkey, and the United States.
AFRMF · Verdict
Moderate reward · elevated risk
AFRMF's standout is volatility; cash flow and profitability weigh on the picture.
Based on 88% data coverage
AFRMF · Verdict
Above average
-15% free-cash-flow margin
-10% net margin · -43% ROE
Rev +4.8% CAGR · earnings +25.1%
Model-based scoring. For information only — not financial advice.
Alphaform AG, together with its subsidiaries, engages in the provision of generative 3D layering technologies, and manufacture of medical products in Germany, rest of Europe, Turkey, and the United States. It operates through AM Plastics/Modelling, AM Metal/Rapid Tooling, and Precision Casting segments. The company is listed on the PINK in USA, operating in the Industrials sector, with a market capitalisation of 748.00.
The scoring profile indicates limited reward potential at this time, with valuation and momentum offering the most support. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.
For informational purposes only. Not financial advice.